C-Type Natriuretic Peptide Engrafted Antibodies


Ontology type: sgo:Patent     


Patent Info

DATE

2019-10-17T00:00

AUTHORS

BROCKSCHNIEDER DAMIAN , Hofmeister Lucas , NOACK CLAUDIA , TEBBE JAN , WALSH STUART , WILMEN ANDREAS , WUNDER FRANK

ABSTRACT

The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "BROCKSCHNIEDER DAMIAN", 
        "type": "Person"
      }, 
      {
        "name": "Hofmeister Lucas", 
        "type": "Person"
      }, 
      {
        "name": "NOACK CLAUDIA", 
        "type": "Person"
      }, 
      {
        "name": "TEBBE JAN", 
        "type": "Person"
      }, 
      {
        "name": "WALSH STUART", 
        "type": "Person"
      }, 
      {
        "name": "WILMEN ANDREAS", 
        "type": "Person"
      }, 
      {
        "name": "WUNDER FRANK", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11897-010-0016-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022530445", 
          "https://doi.org/10.1007/s11897-010-0016-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-10-17T00:00", 
    "description": "

The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof.

", "id": "sg:patent.WO-2019197477-A1", "name": "C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.420044.6", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/WO-2019197477-A1" ], "sdDataset": "patents", "sdDatePublished": "2022-08-04T17:25", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/patent/patent_50.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.WO-2019197477-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.WO-2019197477-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.WO-2019197477-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.WO-2019197477-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

53 TRIPLES      14 PREDICATES      16 URIs      8 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.WO-2019197477-A1 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nedba95cf89a24e70b3fb201ff0307191
4 schema:citation sg:pub.10.1007/s11897-010-0016-6
5 schema:datePublished 2019-10-17T00:00
6 schema:description <p num="0000">The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof.</p>
7 schema:name C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES
8 schema:recipient grid-institutes:grid.420044.6
9 schema:sameAs https://app.dimensions.ai/details/patent/WO-2019197477-A1
10 schema:sdDatePublished 2022-08-04T17:25
11 schema:sdLicense https://scigraph.springernature.com/explorer/license/
12 schema:sdPublisher Ne2163cc56b0b49df90b3acf94e98a234
13 sgo:license sg:explorer/license/
14 sgo:sdDataset patents
15 rdf:type sgo:Patent
16 N07626ca5856c45c6a8d7f8b92e0fbe37 rdf:first N52fcc4b732b14924b03f045721e457f3
17 rdf:rest N541342f1a1af45ba86c137dcce387ba9
18 N13be456096844d1fa8b056a2f8ae6522 rdf:first N3ff430c76e1e4d679eb136bbb3a6f86b
19 rdf:rest rdf:nil
20 N217f9f21b06d4324a881327a864f7bb3 schema:name WILMEN ANDREAS
21 rdf:type schema:Person
22 N3f861e4f6af3453581abfa6fd8738905 rdf:first N4b1bf48d762142f5a0c02b74961f3533
23 rdf:rest N07626ca5856c45c6a8d7f8b92e0fbe37
24 N3ff430c76e1e4d679eb136bbb3a6f86b schema:name WUNDER FRANK
25 rdf:type schema:Person
26 N45d88f3599a946e684a8b2a5d6ee84cb rdf:first N217f9f21b06d4324a881327a864f7bb3
27 rdf:rest N13be456096844d1fa8b056a2f8ae6522
28 N4b1bf48d762142f5a0c02b74961f3533 schema:name Hofmeister Lucas
29 rdf:type schema:Person
30 N52fcc4b732b14924b03f045721e457f3 schema:name NOACK CLAUDIA
31 rdf:type schema:Person
32 N541342f1a1af45ba86c137dcce387ba9 rdf:first N890f447ac93b47b6a58a03f99abad1e6
33 rdf:rest Nbf44cf0f2edd43429d969da290f23b9c
34 N63032b88600144e6bb9245d1ecc84990 schema:name BROCKSCHNIEDER DAMIAN
35 rdf:type schema:Person
36 N890f447ac93b47b6a58a03f99abad1e6 schema:name TEBBE JAN
37 rdf:type schema:Person
38 N8a6a8911ac6b4b908e0d570a45eb5860 schema:name WALSH STUART
39 rdf:type schema:Person
40 Nbf44cf0f2edd43429d969da290f23b9c rdf:first N8a6a8911ac6b4b908e0d570a45eb5860
41 rdf:rest N45d88f3599a946e684a8b2a5d6ee84cb
42 Ne2163cc56b0b49df90b3acf94e98a234 schema:name Springer Nature - SN SciGraph project
43 rdf:type schema:Organization
44 Nedba95cf89a24e70b3fb201ff0307191 rdf:first N63032b88600144e6bb9245d1ecc84990
45 rdf:rest N3f861e4f6af3453581abfa6fd8738905
46 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
47 rdf:type schema:DefinedTerm
48 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
49 rdf:type schema:DefinedTerm
50 sg:pub.10.1007/s11897-010-0016-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022530445
51 https://doi.org/10.1007/s11897-010-0016-6
52 rdf:type schema:CreativeWork
53 grid-institutes:grid.420044.6 schema:Organization
 




Preview window. Press ESC to close (or click here)


...